← Back to Clinical Trials
Recruiting NCT07390435

NCT07390435 Feasibility and Acceptability of Collecting Sociodemographic Data in CCTG Trials

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07390435
Status Recruiting
Phase
Sponsor Canadian Cancer Trials Group
Condition Cancer
Study Type OBSERVATIONAL
Enrollment 1,000 participants
Start Date 2026-05-15
Primary Completion 2027-01-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Social Determinants of Health Questionnaire

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 1,000 participants in total. It began in 2026-05-15 with a primary completion date of 2027-01-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study is being done to answer the following question: Are patients on a clinical trial willing to provide answers to questions about their social, economic, and environmental factors-sometimes called social determinants of health-which affect people's health experiences and access to care. These factors may include income, education, employment, housing, social supports, and experiences with discrimination or stress. Participation will help researchers better understand barriers to participating in clinical trials and access to health care.

Eligibility Criteria

Inclusion Criteria: * Adults (≥18 years) who are either: * Currently being screened and consented to a CCTG trial (prospective). * Already enrolled in an ongoing CCTG trial and still under follow-up (retrospective). Exclusion Criteria: * Participants already enrolled or expected to enroll in a CCTG trial that is also collecting the SDoH Questionnaire.

Contact & Investigator

Central Contact

Anna Johnson

✉ ajohnson@ctg.queensu.ca

📞 613-533-6430

Principal Investigator

Leah Lambert

STUDY CHAIR

BCCA - Vancouver Cancer Centre, Vancouver, BC Canada

Frequently Asked Questions

Who can join the NCT07390435 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07390435 currently recruiting?

Yes, NCT07390435 is actively recruiting participants. Contact the research team at ajohnson@ctg.queensu.ca for enrollment information.

Where is the NCT07390435 trial being conducted?

This trial is being conducted at Kelowna, Canada, Prince George, Canada, Victoria, Canada, Saint John, Canada and 4 additional locations.

Who is sponsoring the NCT07390435 clinical trial?

NCT07390435 is sponsored by Canadian Cancer Trials Group. The principal investigator is Leah Lambert at BCCA - Vancouver Cancer Centre, Vancouver, BC Canada. The trial plans to enroll 1,000 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology